These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33058338)

  • 1. A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS.
    Laffita-Mesa JM; Nennesmo I; Paucar M; Svenningsson P
    Mov Disord; 2021 Feb; 36(2):508-514. PubMed ID: 33058338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
    Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
    Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
    Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
    Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
    Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
    Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
    Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
    Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
    Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
    Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
    Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Mergener R; Furtado GV; de Mattos EP; Leotti VB; Jardim LB; Saraiva-Pereira ML
    Neuromolecular Med; 2020 Mar; 22(1):133-138. PubMed ID: 31587151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.
    Tavares de Andrade HM; Cintra VP; de Albuquerque M; Piccinin CC; Bonadia LC; Duarte Couteiro RE; Sabino de Oliveira D; Claudino R; Magno Gonçalves MV; Dourado MET; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Bulle Oliveira AS; Nucci A; Lopes-Cendes I; Marques W; França MC
    Neurobiol Aging; 2018 Sep; 69():292.e15-292.e18. PubMed ID: 29934271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
    Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
    PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades.
    Wu C; Cai Q; You H; Zhou X; Chen D; Mo G; Li X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e663. PubMed ID: 30920184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
    Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia.
    Rubino E; Mancini C; Boschi S; Ferrero P; Ferrone M; Bianca S; Zucca M; Orsi L; Pinessi L; Govone F; Vacca A; Gai A; Giordana MT; Brusco A; Rainero I
    Neurobiol Aging; 2019 Jan; 73():231.e7-231.e9. PubMed ID: 30342763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 levels in the brain tissue of ALS cases with and without
    Yang Y; Halliday GM; Kiernan MC; Tan RH
    Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
    Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
    Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.
    Naruse H; Matsukawa T; Ishiura H; Mitsui J; Takahashi Y; Takano H; Goto J; Toda T; Tsuji S
    Neurogenetics; 2019 May; 20(2):65-71. PubMed ID: 30847648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
    Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
    JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The repeat length of
    Tang L; Chen L; Liu X; He J; Ma Y; Zhang N; Fan D
    Front Neurol; 2022; 13():939775. PubMed ID: 35989899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.